Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Receivables: 2020-2025

Historic Receivables for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $2,629.

  • Molecular Partners Ag's Receivables fell 31.35% to $2,629 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 19.97%. This contributed to the annual value of $2.7 million for FY2024, which is 21.05% up from last year.
  • Molecular Partners Ag's Receivables amounted to $2,629 in Q3 2025, which was down 39.63% from $4,354 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Receivables high stood at $28.0 million for Q4 2021, and its period low was $1,679 during Q2 2023.
  • For the 3-year period, Molecular Partners Ag's Receivables averaged around $457,920, with its median value being $3,727 (2024).
  • Its Receivables has fluctuated over the past 5 years, first surged by 541.90% in 2021, then plummeted by 95.94% in 2022.
  • Molecular Partners Ag's Receivables (Quarterly) stood at $28.0 million in 2021, then plummeted by 95.94% to $1.1 million in 2022, then soared by 100.43% to $2.3 million in 2023, then grew by 20.06% to $2.7 million in 2024, then slumped by 31.35% to $2,629 in 2025.
  • Its Receivables was $2,629 in Q3 2025, compared to $4,354 in Q2 2025 and $4,423 in Q1 2025.